AML with CBFB–MYH11 rearrangement demonstrate RAS pathway alterations in 92% of all cases including a high frequency of NF1 deletions
Open Access
- 18 February 2010
- journal article
- letter
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 24 (5), 1065-1069
- https://doi.org/10.1038/leu.2010.22
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Nf1 deficiency cooperates with oncogenic K-RAS to induce acute myeloid leukemia in miceBlood, 2009
- Patients With Acute Myeloid Leukemia and RAS Mutations Benefit Most From Postremission High-Dose Cytarabine: A Cancer and Leukemia Group B StudyJournal of Clinical Oncology, 2008
- Exon 8 splice site mutations in the gene encoding the E3-ligase CBL are associated with core binding factor acute myeloid leukemiasHaematologica, 2008
- Gene-expression profiling identifies distinct subclasses of core binding factor acute myeloid leukemiaBlood, 2007
- Adverse Prognostic Significance of KIT Mutations in Adult Acute Myeloid Leukemia With inv(16) and t(8;21): A Cancer and Leukemia Group B StudyJournal of Clinical Oncology, 2006
- Implications of NRAS mutations in AML: a study of 2502 patientsBlood, 2006
- Identification of genes that synergize with Cbfb-MYH11 in the pathogenesis of acute myeloid leukemiaProceedings of the National Academy of Sciences, 2004
- Molecular genetics of human leukemias: New insights into therapySeminars in Hematology, 2002